Lemon Healthcare Hits Daily Limit on Day 2 of Trading, Up 22%; D&D Pharmatech, PharmaResearch Rally

According to E-Daily, on July 8, South Korea's biotech sector showed strong performance. Lemon Healthcare, which fell 6% on its debut day, reversed course and closed at its daily price limit of 12,220 Korean won, up 22.2% from the prior close. D&D Pharmatech gained 12.38% to 85,300 won, while PharmaResearch rose 8.44% to 340,500 won, as investors repositioned following market volatility earlier in the session.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments